Skip to main content

Upcoming holiday closures 

Quest Patient Service Centers will be closed on Friday, July 3 and Saturday, July 4, 2026, in observance of Independence Day, and to give our frontline team the time to recharge. Don't let the holiday interrupt your care. Plan your visit today.

Hide
Quest Diagnostics

US Patterns in Clinical Islet Autoantibody Ordering and Results Show Key Differences After Teplizumab Regulatory Approval

US Patterns in Clinical Islet Autoantibody Ordering and Results Show Key Differences After Teplizumab Regulatory Approval

Authors: Dixit SB, Marcelli M, Tong C, Chen Z, Bare LA, Sims EK

Citation: J Clin Endocrinol Metab. 2026 May 15:dgag200. doi: 10.1210/clinem/dgag200. Online ahead of print.

Specialties: Cardiology, Endocrinology

Related content

Test FAQ
Autoantibodies and Type 1 Diabetes (T1D)
Publication
Insulin Resistance is Associated with Incident Prediabetes and Type 2 Diabetes in Normoglycemic Individuals
Publication
Glycemic Control in Patients with Employer-Sponsored Health Benefits
Audio Podcast
Action From Insight: Tackling Insulin Resistance

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.